|
MAP4K5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.21644966006352E-15 |
| Normal-vs-Stage2 |
3.42859962643161E-10 |
| Normal-vs-Stage3 |
6.1739502399405E-13 |
| Normal-vs-Stage4 |
2.86304313590335E-12 |
| Stage1-vs-Stage2 |
3.648000E-01 |
| Stage1-vs-Stage3 |
2.140600E-01 |
| Stage1-vs-Stage4 |
5.563900E-02 |
| Stage2-vs-Stage3 |
9.763400E-01 |
| Stage2-vs-Stage4 |
4.255200E-01 |
| Stage3-vs-Stage4 |
4.076800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
8.2646000000075E-05 |
| Normal-vs-Asian |
1.6105000000266E-08 |
| Caucasian-vs-AfricanAmerican |
2.958000E-01 |
| Caucasian-vs-Asian |
6.311600E-01 |
| AfricanAmerican-vs-Asian |
5.580800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.88178419700125E-16 |
| Normal-vs-Female |
1.6251444634463E-12 |
| Male-vs-Female |
2.271800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.37532216118552E-12 |
| Normal-vs-Age(41-60Yrs) |
5.10702591327572E-15 |
| Normal-vs-Age(61-80Yrs) |
1.63735691671718E-12 |
| Normal-vs-Age(81-100Yrs) |
2.060900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.181800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.268100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.409600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.188000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.784200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.890400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.187970E-01 |
| Classical-VS-Follicular |
1.198110E-02 |
| Classical-VS-Other |
3.822200E-01 |
| Classical-VS-Normal |
1.6636692024008E-12 |
| Tall-VS-Follicular |
9.352600E-01 |
| Tall-VS-Other |
9.472600E-01 |
| Tall-VS-Normal |
1.70539999899688E-08 |
| Follicular-VS-Other |
9.848800E-01 |
| Follicular-VS-Normal |
2.30782060128831E-12 |
| Other-VS-Normal |
1.098350E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
9.33230048794087E-10 |
| N0-vs-N1 |
5.571600E-01 |
|
|
